 Boston, Massachusetts--Newsfile Corp. - October 18, 2021 - Block Leviton is investigating Revance Therapeutics, Inc. NASDAQ: RVNC for potential securities law violations. Investors who have lost money in their Revance Therapeutics, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit is this all about?On October 15, 2021, the U.S. Food and Drug Administration FDA issued a complete response letter CRL to Revance... 